global situation and disease burden for cholera€¦ · cholera and its control availability of...
TRANSCRIPT
Ad-hoc group of experts on cholera vaccines 28 October 2009
Global Situation and Disease Burden for Cholera
David A Sack, M.D. Professor, Dept of International Health,
Johns Hopkins and formerly the
Executive Director of ICDDR,B
Strategic Advisory Group of Experts on Immunization
28 October, 2009
Ad-hoc group of experts on cholera vaccines 28 October 2009
Cholera is caused by intestinal infection with V cholerae O1 or O139
Severe watery diarrhea leading to dehydration and shock within a few hours.
Is adapted to water but is also capable of causing severe epidemics
Healthy people can be dead in a few hours
Massive fluid replacement may be needed for treatment
Ad-hoc group of experts on cholera vaccines 28 October 2009
Cholera is caused by poverty, lack of sanitation and clean water
Cholera as an issue of equity
– Lack of clean water – Lack of sanitation – Lack of access to treatment
Those most vulnerable can be provided with vaccines
Ad-hoc group of experts on cholera vaccines 28 October 2009
PRESS RELEASE 14th October, 2009
“Kenya’s Public Health Minister Beth Mugo has issued a new cholera alert and urged Kenyans to observe hygiene. The outbreak, which has affected parts of North Eastern, Eastern, Rift Valley and Nairobi provinces, has killed 48 people.” Photo from C.L. Chaignat
Ad-hoc group of experts on cholera vaccines 28 October 2009
Cholera is changing…and getting worse (1)
Old Concepts New Findings Easily treated with rehydration therapy
• Case fatality rates exceed 4% in many areas due to lack of adequate treatment facilities, resources, and training
• Most cholera deaths occur in patients who do not reach treatment facility
Generally sensitive to antibiotics & Single dose is adequate
• Increasingly resistant to standard antibiotics
• Multiple doses of antibiotics are needed because of increasing MICs
Ad-hoc group of experts on cholera vaccines 28 October 2009
Cholera is changing…and getting worse(2)
Old Concepts New Findings Worry of threat of serotype O139
• Threat of O139 remains – but not currently a public health problem
• Immediate threat is the new El Tor hybrid strains with classical toxin… associated with more severe disease
Africa has (unpredictable) outbreaks / Asia is endemic
• Both Africa and Asia have endemic cholera.
• Surveillance will assist in planning for cholera control.
Ad-hoc group of experts on cholera vaccines 28 October 2009
Cholera is changing…and getting worse (3)
Old Concepts New Findings
Outbreaks have brief duration
• Recent outbreaks are prolonged – up to 9 months
Cholera control consists of improved water and sanitation and case management
• Control methods include water and sanitation and case management, but these are synergistically effective if combined with vaccines
Ad-hoc group of experts on cholera vaccines 28 October 2009
Disease Burden of Cholera
Ad-hoc group of experts on cholera vaccines 28 October 2009
Geographical distribution of cholera cases in Africa, 1995–2005
Cases of cholera or AWD are noted throughout sub-saharan Africa
Ad-hoc group of experts on cholera vaccines 28 October 2009
Cholera in Asia
Ad-hoc group of experts on cholera vaccines 28 October 2009
Example of Zimbabwe
22%
20% 14% 12%
93,482 cases Crude CFR 4.4%
Ad-hoc group of experts on cholera vaccines 28 October 2009
Most Deaths Occur Among Patients Who Do Not Reach Health Facility
Cholera in Eastern DRC 2000-2007
Ad-hoc group of experts on cholera vaccines 28 October 2009
0
500
1000
1500
2000
2500
3000
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2
Jan Feb Mar Apr May Jun Jul Aug Sep
Estim
ated
num
ber o
f cas
es
Hospital Surveillance, Dhaka Hospital ICDDR,B January - September, 2009
VCO1 ETEC Rota
Ad-hoc group of experts on cholera vaccines 28 October 2009
Aggregated distribution of reported cholera cases over 10 years in India, 1997-2006
• Most of the states reported cholera
• States without cholera were those that did not have any surveillance in place
• Potential to occur anywhere in India
Ad-hoc group of experts on cholera vaccines 28 October 2009
Disease Burden of Cholera -Official and Unofficial Estimates-
Reported to WHO (annually) – About 250,000 cases – 2,000 to 6,000 deaths – 90%+ from Africa
Usual numbers that are cited*. – 3 to 5 million cases – 120,000 deaths
* New Vaccine Development Establishing Priorities VOLUME II Diseases of Importance in Developing Countries . Part Two of a Two-Part Study by the Committee on Issues and Priorities for New Vaccine Development Division of Health Promotion and Disease Prevention and Division of International Health INSTITUTE OF MEDICINE, NATIONAL ACADEMIES PRESS. Washington, D.C.1986. www.nap.edu
Africa Asia Total # cases (x1000)
1,340 1,210 2,550
# deaths 160,000 50,000 210,000 More deaths estimated from Africa because of higher CFR and higher numbers who do not receive effective treatment
Burden based on recent estimates of incidence and case fatality rates for countries in Africa and Asia
Methods for estimates are available from David Sack, 2009
Ad-hoc group of experts on cholera vaccines 28 October 2009
In Bangladesh, cholera is becoming more severe
Proportion of cholera cases arriving at hospital in shock has been increasing
Corresponds with the appearance of new El Tor / classical hybrid strains
Similar clinical data is not available from Africa, but the strains are similar
Siddique AK, Nair GB, Alam M, Sack DA, et al. El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect. 2009 Aug 14:1-6
Ad-hoc group of experts on cholera vaccines 28 October 2009
Epidemics / Endemic / Outbreaks
Cholera is now endemic in many countries of Asia and Africa
– Variable attack rates by season and year
– El Tor cholera lives in surface and brackish water and can spread when there is breakdown in sanitation
We often use the term “epidemic” or “outbreak” to explain a sudden increase in the number of cases
From a practical sense, a country can be said to have endemic cholera if it has had documented cases during 3 or the last 5 years.
Improved surveillance can help to refine rates of cholera as well as the seasons and groups of highest risk
Ad-hoc group of experts on cholera vaccines 28 October 2009
Improved surveillance is needed to maximize impact of cholera vaccine
Surveillance is needed to
• help target those at highest risk by…
• Age • SES groups • Geographic
• help target season • Focus messages about
cholera and its control
Availability of vaccine will have other benefits for cholera control
• May improve surveillance
• Improve messages about cholera control
• Help bring cholera “out of the shadows.”
Ad-hoc group of experts on cholera vaccines 28 October 2009
Summary of key points (1) Issue Key points
Burden of disease • Burden of disease is much higher than is reflected among cases reported to WHO. • Case fatality rates about 4% in Africa • Most deaths occur in patients who do not reach treatment facility
Antibiotic resistance • Increasingly resistant to standard antibiotics
Severity of the illness • Disease appears to becoming more virulent with more patients arriving in shock, at least in Bangladesh
Endemic vs epidemic • Both Africa and Asia have endemic cholera
Ad-hoc group of experts on cholera vaccines 28 October 2009
Summary of key points (2) Issue Key points
Duration of cholera “outbreaks”
• Recent outbreaks are prolonged and vaccines could reduce numbers of cases and deaths, if used promptly.
Relation to traditional methods of control
• Vaccines are synergistic with water and sanitation and will reduce the numbers of cases requiring treatment
Equity • Vaccines can be given to the poor and vulnerable…those who are less likely to receive treatment when ill
Availability of treatment
• “Treatment delayed is treatment denied.” Cholera kills in a matter of hours.